• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of angiotensin-converting enzyme inhibitors immediately after stroke: Commentary.

作者信息

Kaul Subhash

机构信息

Department of Neurology, Nizam Institute of Medical Sciences, Hyderabad, India.

出版信息

Ann Indian Acad Neurol. 2010 Jul;13(3):163. doi: 10.4103/0972-2327.70872.

DOI:10.4103/0972-2327.70872
PMID:21085523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2981750/
Abstract
摘要

相似文献

1
Use of angiotensin-converting enzyme inhibitors immediately after stroke: Commentary.中风后立即使用血管紧张素转换酶抑制剂：评论
Ann Indian Acad Neurol. 2010 Jul;13(3):163. doi: 10.4103/0972-2327.70872.
2
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂在心肌梗死、中风和死亡风险方面的比较：一项荟萃分析。
J Hypertens. 2008 Jul;26(7):1282-9. doi: 10.1097/HJH.0b013e328306ebe2.
3
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): rationale, design, and methodology.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂在 MRI 上对卒中复发风险和脑白质病变及无症状性脑梗死纵向进展的比较（CEREBRAL 研究）：基本原理、设计和方法。
Int J Stroke. 2015 Apr;10(3):452-6. doi: 10.1111/ijs.12085. Epub 2013 Jul 9.
4
Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.血管紧张素转化酶抑制剂/血管紧张素 II 受体阻滞剂与脑卒中患者肺炎风险的关系。
J Hypertens. 2012 Nov;30(11):2223-9. doi: 10.1097/HJH.0b013e328357a87a.
5
Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.血管紧张素转换酶抑制剂比血管紧张素受体阻滞剂降低死亡率：系统评价和荟萃分析。
Eur J Prev Cardiol. 2017 Dec;24(18):1914-1924. doi: 10.1177/2047487317728766. Epub 2017 Sep 1.
6
Incidence of new stroke or new myocardial infarction or death at 39-month follow up in patients with diabetes mellitus, hypertension, or both treated with and without angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.在接受血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂治疗或未接受治疗的糖尿病、高血压或两者并存的患者中，随访 39 个月时新发卒中和/或新发心肌梗死或死亡的发生率。
Am J Ther. 2009 Jan-Feb;16(1):2-4. doi: 10.1097/MJT.0b013e31804d1b53.
7
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.非心脏手术前停用与继续使用血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂：非心脏手术患者队列评估前瞻性队列中的血管事件分析
Anesthesiology. 2017 Jan;126(1):16-27. doi: 10.1097/ALN.0000000000001404.
8
Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.冠心病且无心力衰竭或左心室收缩功能障碍患者使用血管紧张素转换酶抑制剂：长期随机对照试验综述
Arch Intern Med. 2006 Apr 10;166(7):787-96. doi: 10.1001/archinte.166.7.787.
9
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂对预防中风的作用：哪一种更好？
Int J Cardiol. 2016 Nov 15;223:56-57. doi: 10.1016/j.ijcard.2016.08.150. Epub 2016 Aug 8.
10
Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke.大鼠缺血性卒中中神经保护性血管紧张素转换酶2的激活
Hypertension. 2015 Jul;66(1):141-8. doi: 10.1161/HYPERTENSIONAHA.115.05185. Epub 2015 May 4.

引用本文的文献

1
Angiotensin-receptor blockade in acute stroke.急性卒中中的血管紧张素受体阻断
Ann Indian Acad Neurol. 2011 Apr;14(2):142-3. doi: 10.4103/0972-2327.82825.

本文引用的文献

1
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.成人缺血性卒中早期管理指南：美国心脏协会/美国卒中协会卒中委员会、临床心脏病学委员会、心血管放射学与介入委员会以及动脉粥样硬化性外周血管疾病与研究跨学科工作组护理质量与转归委员会制定的指南：美国神经病学学会肯定本指南作为神经病学教育工具的价值。
Stroke. 2007 May;38(5):1655-711. doi: 10.1161/STROKEAHA.107.181486. Epub 2007 Apr 12.
2
Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity.中风前使用血管紧张素转换酶抑制剂对缺血性中风严重程度的影响。
BMC Neurol. 2005 Jun 10;5(1):10. doi: 10.1186/1471-2377-5-10.
3
Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.首次发生缺血性卒中患者使用血管紧张素转换酶抑制剂与血浆C反应蛋白浓度降低有关。
Stroke. 2003 Dec;34(12):2922-9. doi: 10.1161/01.STR.0000099124.84425.BB. Epub 2003 Nov 6.
4
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.在6105名曾患中风或短暂性脑缺血发作的个体中，基于培哚普利的降压方案的随机试验。
Lancet. 2001 Sep 29;358(9287):1033-41. doi: 10.1016/S0140-6736(01)06178-5.
5
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.血管紧张素转换酶抑制剂雷米普利对高危患者心血管事件的影响。
N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301.
6
Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke.
Stroke. 1997 Mar;28(3):580-3. doi: 10.1161/01.str.28.3.580.
7
Hypertension in acute ischemic strokes. Not to treat.急性缺血性卒中中的高血压。不予治疗。
Arch Neurol. 1985 Oct;42(10):999-1000. doi: 10.1001/archneur.1985.04060090081018.
8
Angiotensin-converting enzyme inhibition and regional cerebral blood flow in acute stroke.急性卒中时血管紧张素转换酶抑制与局部脑血流量
J Cardiovasc Pharmacol. 1989 Nov;14(5):722-9. doi: 10.1097/00005344-198911000-00008.